RxDoctor Payments Data

David Baek, DPM

Podiatrist · Gaithersburg, MDNPI 1508884321

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.4%), education and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 45.6% of the total. Reporting peaked in 2021 at $1,627 and has fallen 93.2% since, to $111 in 2025.

$2,671in general payments, 2019–2025

Across 56 payments — averaging $47.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$1K
  • Smith+Nephew$187
  • Organogenesis Inc.$183
  • Integra Lifesciences Corporation$150
  • Stryker$133
  • Kerecis Limited$112
  • plus $690 from 16 others

What the payments were for

  • Speaking & faculty fees$1255%
  • Food & beverage$1,34650%
  • Education$1,20045%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,671 in reported general payments places this provider in the 75th percentile of 183 podiatrist providers in Maryland.

See all podiatrist providers in Maryland

Medicare billing

Part B allowed, 2024
$224,288
Medicare patients
696
Services billed
2,354

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine222$4,376
Ciclopirox14$663
Mupirocin71$509
Gabapentin57$312
Doxycycline Monohydrate27$234
Meloxicam30$117
Cephalexin12$73

Paid to pharmacies, not to this prescriber.

Other podiatrist in Gaithersburg

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →